Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 17, 2004. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions and does not contain financial performance data.
Material Changes
On November 16, 2004, the GlaxoSmithKline Employee Trust ("the GSK Trust") transferred 7,510 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. The company was advised of these transactions on November 17, 2004.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. It strictly details the mechanics of the share transfer and the nature of the GSK Trust as a discretionary trust for current and former employees.
Investor Verification Points
- Verify the total number of shares transferred (7,510) and the specific plan involved (SmithKline Beecham Employee Share Option Plan 1991).
- Confirm the status of the GSK Trust as a discretionary trust benefiting employees and former employees.
- Note that three directors (Dr J-P Garnier, Dr T Yamada, and Mr J D Coombe) hold interests in the shares held by the GSK Trust in the same capacity as other employees.